ATE291419T1 - Feste dosierungsform mit desmopressin - Google Patents

Feste dosierungsform mit desmopressin

Info

Publication number: ATE291419T1
Authority: AT; Austria
Prior art keywords: desmopressin; solid dosage; dosage form; diluent; carrier
Prior art date: 2003-04-30

Application number

AT03009659T

Other languages

English (en)

Inventor

Hakan Lomryd

Helena Nicklasson

Lars-Erik Olsson

Original Assignee

Ferring Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-30

Filing date

2003-04-30

Publication date

2005-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32981781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE291419(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-04-30 Application filed by Ferring Bv filed Critical Ferring Bv

2005-04-15 Application granted granted Critical

2005-04-15 Publication of ATE291419T1 publication Critical patent/ATE291419T1/de

Links

108010000437 Deamino Arginine Vasopressin Proteins 0.000 title abstract 4
NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 title abstract 4
229960004281 desmopressin Drugs 0.000 title abstract 4
239000007909 solid dosage form Substances 0.000 title abstract 4
239000004480 active ingredient Substances 0.000 abstract 2
239000003085 diluting agent Substances 0.000 abstract 2
238000004519 manufacturing process Methods 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
239000000546 pharmaceutical excipient Substances 0.000 abstract 2
239000000126 substance Substances 0.000 abstract 2
150000002016 disaccharides Chemical class 0.000 abstract 1
150000004676 glycans Chemical class 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
150000002772 monosaccharides Chemical class 0.000 abstract 1
229920001542 oligosaccharide Polymers 0.000 abstract 1
150000002482 oligosaccharides Chemical class 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
229920001282 polysaccharide Polymers 0.000 abstract 1
239000005017 polysaccharide Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Jellies, Jams, And Syrups (AREA)

AT03009659T 2003-04-30 2003-04-30 Feste dosierungsform mit desmopressin ATE291419T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03009659A EP1473029B1 (de)	2003-04-30	2003-04-30	Feste Dosierungsform mit Desmopressin

Publications (1)

Publication Number	Publication Date
ATE291419T1 true ATE291419T1 (de)	2005-04-15

Family

ID=32981781

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03009659T ATE291419T1 (de)	2003-04-30	2003-04-30	Feste dosierungsform mit desmopressin

Country Status (18)

Country	Link
EP (2)	EP1473029B1 (de)
JP (1)	JP4597124B2 (de)
KR (1)	KR100766455B1 (de)
CN (1)	CN100438857C (de)
AT (1)	ATE291419T1 (de)
AU (1)	AU2004233596B2 (de)
CA (1)	CA2486833C (de)
DE (1)	DE60300414T2 (de)
DK (1)	DK1473029T3 (de)
ES (1)	ES2236640T3 (de)
MX (1)	MXPA05011591A (de)
NO (1)	NO331205B1 (de)
NZ (1)	NZ542653A (de)
PL (1)	PL211799B1 (de)
PT (1)	PT1473029E (de)
RU (1)	RU2290945C2 (de)
SI (1)	SI1473029T1 (de)
WO (1)	WO2004096181A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0210397D0 (en)	2002-05-07	2002-06-12	Ferring Bv	Pharmaceutical formulations
ATE301990T1 (de) *	2003-07-25	2005-09-15	Ferring Bv	Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung
CA2490601C (en) *	2003-12-29	2006-05-02	Ferring B.V.	Method for preparing solid dosage form of desmopressin
ES2319054B1 (es)	2007-08-06	2010-02-12	Gp Pharm S.A.	Composicion farmaceutica oral de desmopresina.
CN102423485B (zh) *	2011-12-08	2014-08-06	赵联华	含有醋酸去氨加压素的口服组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8306367L (sv) *	1983-11-18	1985-05-19	Ferring Ab	Antidiuretiskt verkande farmaceutiskt preparat
TW391880B (en) *	1994-01-31	2000-06-01	Yamanouchi Pharma Co Ltd	An oral soluble type compression moulding and its preparation
SE9400918L (sv) *	1994-03-18	1995-09-19	Anne Fjellstad Paulsen	Stabiliserad komposition för oral administrering av peptider
US5849322A (en) *	1995-10-23	1998-12-15	Theratech, Inc.	Compositions and methods for buccal delivery of pharmaceutical agents
US6210699B1 (en) *	1999-04-01	2001-04-03	Watson Pharmaceuticals, Inc.	Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
JP2001139461A (ja) *	1999-11-10	2001-05-22	Ohta Pharmaceut Co Ltd	速崩壊性錠剤
JP4596586B2 (ja) *	2000-01-27	2010-12-08	旭化成ケミカルズ株式会社	トレハロース粒子
CN1473035B (zh) *	2001-07-27	2012-07-18	安斯泰来制药有限公司	含有口腔内迅速崩解片剂用缓释微粒的组合物及其制造方法

2003
- 2003-04-30 AT AT03009659T patent/ATE291419T1/de active
- 2003-04-30 PT PT03009659T patent/PT1473029E/pt unknown
- 2003-04-30 DE DE60300414T patent/DE60300414T2/de not_active Expired - Lifetime
- 2003-04-30 ES ES03009659T patent/ES2236640T3/es not_active Expired - Lifetime
- 2003-04-30 EP EP03009659A patent/EP1473029B1/de not_active Expired - Lifetime
- 2003-04-30 SI SI200330022T patent/SI1473029T1/xx unknown
- 2003-04-30 DK DK03009659T patent/DK1473029T3/da active
2004
- 2004-04-30 CN CNB2004800113540A patent/CN100438857C/zh not_active Expired - Lifetime
- 2004-04-30 EP EP04730504A patent/EP1670439A2/de not_active Withdrawn
- 2004-04-30 RU RU2005131494/15A patent/RU2290945C2/ru active
- 2004-04-30 KR KR1020057020585A patent/KR100766455B1/ko not_active Expired - Lifetime
- 2004-04-30 PL PL379703A patent/PL211799B1/pl unknown
- 2004-04-30 MX MXPA05011591A patent/MXPA05011591A/es active IP Right Grant
- 2004-04-30 CA CA002486833A patent/CA2486833C/en not_active Expired - Lifetime
- 2004-04-30 WO PCT/EP2004/004597 patent/WO2004096181A2/en not_active Ceased
- 2004-04-30 JP JP2006505337A patent/JP4597124B2/ja not_active Expired - Lifetime
- 2004-04-30 NZ NZ542653A patent/NZ542653A/en not_active IP Right Cessation
- 2004-04-30 AU AU2004233596A patent/AU2004233596B2/en not_active Expired
2005
- 2005-10-27 NO NO20055016A patent/NO331205B1/no unknown

Also Published As

Publication number	Publication date
PL379703A1 (pl)	2006-11-13
NZ542653A (en)	2008-04-30
EP1473029A1 (de)	2004-11-03
JP2006524663A (ja)	2006-11-02
KR100766455B1 (ko)	2007-10-15
KR20060012592A (ko)	2006-02-08
CA2486833C (en)	2005-08-02
MXPA05011591A (es)	2005-12-15
AU2004233596B2 (en)	2010-04-08
RU2290945C2 (ru)	2007-01-10
EP1473029B1 (de)	2005-03-23
ES2236640T3 (es)	2005-07-16
SI1473029T1 (en)	2005-10-31
EP1670439A2 (de)	2006-06-21
NO331205B1 (no)	2011-10-31
PT1473029E (pt)	2005-05-31
WO2004096181A3 (en)	2004-12-23
JP4597124B2 (ja)	2010-12-15
DE60300414D1 (de)	2005-04-28
CN100438857C (zh)	2008-12-03
DE60300414T2 (de)	2006-05-11
AU2004233596A1 (en)	2004-11-11
RU2005131494A (ru)	2006-03-20
CA2486833A1 (en)	2004-11-11
NO20055016L (no)	2005-10-27
CN1780608A (zh)	2006-05-31
DK1473029T3 (da)	2005-04-18
PL211799B1 (pl)	2012-06-29
WO2004096181A2 (en)	2004-11-11

Similar Documents

Publication	Publication Date	Title
CA2339991A1 (en)	2000-02-24	Microemulsions as solid dosage forms for oral administration
WO2002101412A3 (en)	2003-03-20	Spray freeze-dried compositions
IL139227A0 (en)	2001-11-25	N-substituted aminotetralins as ligands for the neuropeptide yy5 receptor useful in the treatment of obesity and other disorders
EP1283054A4 (de)	2006-04-12	Medikamente zur behandlung von komplikationen des diabetes und neuropathien, und verwendung davon
NO20011721D0 (no)	2001-04-05	N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
IL159843A0 (en)	2004-06-20	Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
WO2003048164A3 (en)	2003-10-16	Adenosine a2a receptor antagonists
CA2489407A1 (en)	2004-01-22	Lasofoxifene tablet and its coating
EA201190012A1 (ru)	2012-02-28	Твердые лекарственные формы бендамустина
EA200301040A1 (ru)	2004-04-29	Способ производства фармацевтической композиции низкой дозы
WO2004078105A3 (fr)	2004-10-28	Composition de fondaparinux sodique de haute purete
WO2004096823A3 (en)	2005-02-10	Novel ketolide derivatives
ATE329581T1 (de)	2006-07-15	Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
CA2490335A1 (en)	2005-01-25	Pharmaceutical composition as solid dosage form and method for manufacturing thereof
MA26346A1 (fr)	2004-10-01	Compositions de preparation contenant des composes actifs au plan physiologique et instables aux acides et leur procede de production.
BR0013106A (pt)	2002-07-23	Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
EA200400061A1 (ru)	2004-06-24	Фармацевтический состав с замаскированным вкусом и способ его получения
DE60300414D1 (de)	2005-04-28	Feste Dosierungsform mit Desmopressin
HUP0600084A2 (en)	2006-06-28	Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
CA2502582A1 (en)	2004-04-29	Pharmaceutical formulation of olanzapine
WO2004033484A3 (en)	2004-06-10	Use of stable glutamine derivatives to improve drug absorption
TW200640472A (en)	2006-12-01	Solid pharmaceutical composition comprising telithromycin
WO2005020876A3 (en)	2005-06-09	Pharmaceutical composition, method of manufacturing and therapeutic use thereof
WO2004000864A3 (en)	2004-02-26	11-c-substituted ketolides
ATE504555T1 (de)	2011-04-15	Phenylbenzoesäure-derivate, herstellungsverfahren dafür, pharmazeutische zusammensetzungen damit und therapeutische verwendungen damit

Legal Events

Date

Code

Title

Description

2006-04-15

UEP

Publication of translation of european patent specification

Ref document number: 1473029

Country of ref document: EP